Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults

Summary: Background: The COVID-19 pandemic and its consequences have been associated with an increase in poor population mental health. We assessed how depressive symptoms changed among U.S. adults over the course of the COVID-19 pandemic and identified the key risk factors for these symptoms. Meth...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Catherine K. Ettman, Gregory H. Cohen, Salma M. Abdalla, Laura Sampson, Ludovic Trinquart, Brian C. Castrucci, Rachel H. Bork, Melissa A. Clark, Ira Wilson, Patrick M. Vivier, Sandro Galea
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Depression Mental Health Economic inequities Stressors Low-income Wealth Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/30ef7bc5b454459494c2ee6454b1d595
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:30ef7bc5b454459494c2ee6454b1d595
record_format	dspace
spelling	oai:doaj.org-article:30ef7bc5b454459494c2ee6454b1d5952021-12-02T05:04:38ZPersistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults2667-193X10.1016/j.lana.2021.100091https://doaj.org/article/30ef7bc5b454459494c2ee6454b1d5952022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667193X21000879https://doaj.org/toc/2667-193XSummary: Background: The COVID-19 pandemic and its consequences have been associated with an increase in poor population mental health. We assessed how depressive symptoms changed among U.S. adults over the course of the COVID-19 pandemic and identified the key risk factors for these symptoms. Methods: Longitudinal panel study of a nationally representative group of U.S. adults ages 18 years and older surveyed in March-April 2020 (Time 1; N=1441) and March-April 2021 (Time 2; N=1161) in the COVID-19 and Life Stressors Impact on Mental Health and Well-being study (CLIMB). The Patient Health Questionnaire-9 (PHQ-9) was used to define elevated depressive symptoms (cut-off ≥10) and depressive symptoms score (0-27). Findings: The prevalence of elevated depressive symptoms persisted from 27.8% in 2020 (95% CI: 24.9, 30.9) to 32.8% in 2021 (95% CI: 29.1, 36.8). Over time, the central drivers of depressive symptoms were low household income, not being married, and experiencing multiple stressors during the COVID-19 pandemic. The odds ratio of elevated depressive symptoms for low income relative to high income persons increased from 2.3 (95% CI: 1.2, 4.2) in 2020 to 7.0 (95% CI: 3.7, 13.3) in 2021. Fewer people reported experiencing 4 or more COVID-19 stressors in 2021 than in 2020 (47.5% in 2020 vs 37.1% in 2021), but the odds ratio of elevated depressive symptoms associated with 4 or more stressors relative to 1 stressor or less increased from 1.9 (95% CI: 1.2, 3.1) in 2020 to 5.4 (95% CI: 3.2, 9.2) in 2021. Interpretation: The burden of depressive symptoms in the U.S. adult population increased over the course of the COVID-19 pandemic. Mental health gaps grew between populations with different assets and stressor experiences during the COVID-19 pandemic. Funding: CLIMB Time 1 was sponsored by the Rockefeller Foundation-Boston University 3-D Commission. CLIMB Time 2 was sponsored by the de Beaumont Foundation.Catherine K. EttmanGregory H. CohenSalma M. AbdallaLaura SampsonLudovic TrinquartBrian C. CastrucciRachel H. BorkMelissa A. ClarkIra WilsonPatrick M. VivierSandro GaleaElsevierarticleDepressionMental HealthEconomic inequitiesStressorsLow-incomeWealthPublic aspects of medicineRA1-1270ENThe Lancet Regional Health. Americas, Vol 5, Iss , Pp 100091- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Depression Mental Health Economic inequities Stressors Low-income Wealth Public aspects of medicine RA1-1270
spellingShingle	Depression Mental Health Economic inequities Stressors Low-income Wealth Public aspects of medicine RA1-1270 Catherine K. Ettman Gregory H. Cohen Salma M. Abdalla Laura Sampson Ludovic Trinquart Brian C. Castrucci Rachel H. Bork Melissa A. Clark Ira Wilson Patrick M. Vivier Sandro Galea Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
description	Summary: Background: The COVID-19 pandemic and its consequences have been associated with an increase in poor population mental health. We assessed how depressive symptoms changed among U.S. adults over the course of the COVID-19 pandemic and identified the key risk factors for these symptoms. Methods: Longitudinal panel study of a nationally representative group of U.S. adults ages 18 years and older surveyed in March-April 2020 (Time 1; N=1441) and March-April 2021 (Time 2; N=1161) in the COVID-19 and Life Stressors Impact on Mental Health and Well-being study (CLIMB). The Patient Health Questionnaire-9 (PHQ-9) was used to define elevated depressive symptoms (cut-off ≥10) and depressive symptoms score (0-27). Findings: The prevalence of elevated depressive symptoms persisted from 27.8% in 2020 (95% CI: 24.9, 30.9) to 32.8% in 2021 (95% CI: 29.1, 36.8). Over time, the central drivers of depressive symptoms were low household income, not being married, and experiencing multiple stressors during the COVID-19 pandemic. The odds ratio of elevated depressive symptoms for low income relative to high income persons increased from 2.3 (95% CI: 1.2, 4.2) in 2020 to 7.0 (95% CI: 3.7, 13.3) in 2021. Fewer people reported experiencing 4 or more COVID-19 stressors in 2021 than in 2020 (47.5% in 2020 vs 37.1% in 2021), but the odds ratio of elevated depressive symptoms associated with 4 or more stressors relative to 1 stressor or less increased from 1.9 (95% CI: 1.2, 3.1) in 2020 to 5.4 (95% CI: 3.2, 9.2) in 2021. Interpretation: The burden of depressive symptoms in the U.S. adult population increased over the course of the COVID-19 pandemic. Mental health gaps grew between populations with different assets and stressor experiences during the COVID-19 pandemic. Funding: CLIMB Time 1 was sponsored by the Rockefeller Foundation-Boston University 3-D Commission. CLIMB Time 2 was sponsored by the de Beaumont Foundation.
format	article
author	Catherine K. Ettman Gregory H. Cohen Salma M. Abdalla Laura Sampson Ludovic Trinquart Brian C. Castrucci Rachel H. Bork Melissa A. Clark Ira Wilson Patrick M. Vivier Sandro Galea
author_facet	Catherine K. Ettman Gregory H. Cohen Salma M. Abdalla Laura Sampson Ludovic Trinquart Brian C. Castrucci Rachel H. Bork Melissa A. Clark Ira Wilson Patrick M. Vivier Sandro Galea
author_sort	Catherine K. Ettman
title	Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
title_short	Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
title_full	Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
title_fullStr	Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
title_full_unstemmed	Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults
title_sort	persistent depressive symptoms during covid-19: a national, population-representative, longitudinal study of u.s. adults
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/30ef7bc5b454459494c2ee6454b1d595
work_keys_str_mv	AT catherinekettman persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT gregoryhcohen persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT salmamabdalla persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT laurasampson persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT ludovictrinquart persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT brianccastrucci persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT rachelhbork persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT melissaaclark persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT irawilson persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT patrickmvivier persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults AT sandrogalea persistentdepressivesymptomsduringcovid19anationalpopulationrepresentativelongitudinalstudyofusadults
_version_	1718400581251366912

Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults

Ejemplares similares